Volume 22, Number 8—August 2016
Research
Outbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi Infections after Prostate Biopsies, France, 2014
Table 3
Characteristic | Patient ID |
|||||
---|---|---|---|---|---|---|
A | B | C | D | E | F | |
Date of biopsy | 2011 Nov 23 | 2011 Dec 16 | 2012 May 7 | 2012 May 31 | 2012 July 9 | 2012 Nov 30 |
Patient age at onset, y | 57 | 79 | 75 | 65 | 76 | 68 |
Days between biopsy and urinalysis | 5 | 1 | 8 | 3 | 9 | 2 |
Highest fever, °C | 40 | 39 | None | 39 | 38.4 | None |
Localized symptoms | Yes | Yes | Yes | No | Yes | Yes |
Hospitalization | No | Yes | No | No | No | No |
Urine culture result | S. malt | S. malt | E. coli | S. malt | S. malt | Mixed flora |
Blood culture result | NA | Negative | NA | Negative | NA | K. pne |
Antimicrobial resistance profile† | 1 | 1 | NR | 2 | 3 | NR |
Curative antimicrobial drug treatment | Yes | Yes | Yes | Yes | Yes | Yes |
Apyrexia without proper antimicrobial regimen | Yes | Yes | No | Yes | Yes | Yes |
Immunosuppressants |
No |
No |
No |
No |
No |
No |
*E. coli, Escherichia coli; K. pne, Klebsiella pneumoniae; NA, cultures not requested; NR, not recorded; S. malt, Stenotrophomonas maltophilia. †The antimicrobial-drug resistance profile is shown for S. maltophilia only. Profiles 1 and 2 had only 1 difference across 17 different antimicrobial drugs (ceftazidime-I vs. -S). Of 14 antimicrobial drugs tested for all 4 S. maltophilia patients, profile 3 had 2 differences from profile 2 and 3 differences from profile 1. |
Page created: July 15, 2016
Page updated: July 15, 2016
Page reviewed: July 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.